Litigation Details for Walgreen Co. v. Bausch Health Companies Inc. (N.D. Cal. 2019)
✉ Email this page to a colleague
Walgreen Co. v. Bausch Health Companies Inc. (N.D. Cal. 2019)
Docket | ⤷ Try a Trial | Date Filed | 2019-12-02 |
Court | District Court, N.D. California | Date Terminated | |
Cause | 15:1 Antitrust Litigation | Assigned To | William Haskell Alsup |
Jury Demand | Plaintiff | Referred To | |
Patents | 6,340,475; 6,488,962; 6,635,280; 6,723,340; 7,780,987; 8,323,692 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Walgreen Co. v. Bausch Health Companies Inc.
Details for Walgreen Co. v. Bausch Health Companies Inc. (N.D. Cal. 2019)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2019-12-02 | 1 | Complaint | 13 patents: 14 Patent No. Expiration 6,340,475 (‘475…Book patent (the ‘692 patent), as well as two non-Orange Book listed 20 patents (the ‘667 patent and …and U.S. Patent No. 8,329,215 (“the ‘215 patent”)). 21 155. The ‘215 patent, like the ‘667 patent…26 plaintiffs in the patent lawsuit, paid Lupin, the defendant in the patent lawsuit the reverse of … of the listed patents. The manufacturer must list in the Orange Book any such patents that issue 4 | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |